- Home
- ORGO vs MUA Comparison
ORGO vs MUA Comparison
Compare ORGO & MUA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- MUA
- Stock Information
- Founded
- ORGO 1985
- MUA 1993
- Country
- ORGO United States
- MUA United States
- Employees
- ORGO N/A
- MUA N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- MUA Investment Bankers/Brokers/Service
- Sector
- ORGO Health Care
- MUA Finance
- Exchange
- ORGO Nasdaq
- MUA Nasdaq
- Market Cap
- ORGO 376.8M
- MUA 396.8M
- IPO Year
- ORGO N/A
- MUA N/A
- Fundamental
- Price
- ORGO $2.92
- MUA $10.21
- Analyst Decision
- ORGO Buy
- MUA
- Analyst Count
- ORGO 2
- MUA 0
- Target Price
- ORGO $5.50
- MUA N/A
- AVG Volume (30 Days)
- ORGO 1.6M
- MUA 92.6K
- Earning Date
- ORGO 05-08-2025
- MUA 01-01-0001
- Dividend Yield
- ORGO N/A
- MUA 4.84%
- EPS Growth
- ORGO N/A
- MUA N/A
- EPS
- ORGO N/A
- MUA N/A
- Revenue
- ORGO $458,760,000.00
- MUA N/A
- Revenue This Year
- ORGO $2.73
- MUA N/A
- Revenue Next Year
- ORGO $12.28
- MUA N/A
- P/E Ratio
- ORGO N/A
- MUA N/A
- Revenue Growth
- ORGO 5.35
- MUA N/A
- 52 Week Low
- ORGO $2.28
- MUA $8.61
- 52 Week High
- ORGO $6.71
- MUA $11.43
- Technical
- Relative Strength Index (RSI)
- ORGO 35.44
- MUA 45.72
- Support Level
- ORGO $2.61
- MUA $10.19
- Resistance Level
- ORGO $3.28
- MUA $10.33
- Average True Range (ATR)
- ORGO 0.14
- MUA 0.11
- MACD
- ORGO 0.01
- MUA -0.00
- Stochastic Oscillator
- ORGO 34.59
- MUA 27.38
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About MUA Blackrock MuniAssets Fund Inc
Blackrock Muniassets Fund Inc is a closed-end fund. Its objective is to provide high current income exempt from U.S. federal income taxes by investing in a portfolio of medium- to lower-grade or unrated municipal obligations.